France 2030 — Call for Projects: Demonstrating Real-World Value of Innovations
Purpose: supporting large-scale projects addressing public health objectives that deploy innovative prevention solutions, incorporating health technologies and products, possibly combining several innovations. Application deadlines: 22 September 2026 (now passed); 28 September 2027. Beneficiaries listed in the catalogue: Companies of all sizes; research organisations. Amount listed: For companies: mixed support, with up to 60% of the support as grants and 40% as repayable advances; repayable advances cannot be less than €100k per partner. For research organisations: grants. Catalogue parameters are not a confirmation of eligibility; check the official rules and current timetable.
France 2030's prevention challenge supports projects that evaluate prevention innovations in real-world conditions, linked to public health objectives. Bpifrance's specifications provide for several deadlines; the 22 September 2026 one has passed and the next indicated is 28 September 2027, subject to available funds and changes to the timetable.
Funded by Bpifrance
Run a personalised scan to identify the public grants and funding your company may be able to access.
Who can apply
Beneficiaries listed in the catalogue: Companies of all sizes; research organisations. The call closes in December 2028 at the latest, subject to available funds. Check company size, location, role in the consortium and any exclusions.
Eligibility conditions
Detailed conditions are not fully provided in the catalogue. Check whether funds remain available and the updated version of the specifications.
What the scheme covers
Operations or costs described in the catalogue: innovative prevention solutions incorporating one or more innovative (or presumed innovative) health products or technologies, possibly combined with other innovations, notably digital or organisational, to reduce the prevalence of diseases or predict their incidence, optimise or personalise treatment, prevent complications and improve adherence — notably through patient participation with patient-reported outcomes (PROs) — and adherence to treatment and screening. Eligible themes include infertility, child health, mental health, preventing loss of autonomy, chronic diseases (cancers, diabetes, cardio-neurovascular and cardiometabolic diseases, neurodegenerative diseases, etc.) and promoting healthy behaviours. The specifications prevail for eligible costs, excluded costs, combination rules and reporting obligations.
Amount and funding terms
The catalogue states: For companies: mixed support, with up to 60% of the support as grants and 40% as repayable advances; repayable advances cannot be less than €100k per partner. For research organisations: grants. The amount, rate, base and form (grant, recoverable advance or other) must be checked in the applicable specifications.
How to apply
1) Open the official page of the scheme and download the specifications (cahier des charges). 2) Check the status of the call and the next deadline. 3) Confirm the eligibility of the lead applicant, the partners and the area covered. 4) Prepare the budget and the required supporting documents. 5) Obtain the operator's confirmation before committing any costs. Official source: https://www.bpifrance.fr/download/media-file/84122
Timeline
The 22 September 2026 deadline has passed. The next deadline indicated is 28 September 2027 at noon Paris time; the call may close earlier if the budget runs out. Check whether funds remain available and the latest version of the specifications.
Key facts
- Funder
- Bpifrance
- Type of funding
- Grant
- Status
- Open
- Maximum amount
- €100,000
- Automatically extracted — check the official source
- Closes
- 28 September 2027
- Geographic scope
- All of France
Frequently asked questions
What is the "Demonstrating the value of innovations in real life" call for?
It supports large-scale projects addressing public health objectives that deploy innovative prevention solutions, incorporating health technologies and products, possibly combining several innovations.
Who can apply and on what conditions?
Beneficiaries listed in the catalogue: Companies of all sizes; research organisations. Conditions to be confirmed in the rules, notably whether funds remain available.
What funding and which costs can be covered?
For companies: mixed support, with up to 60% of the support as grants and 40% as repayable advances; repayable advances cannot be less than €100k per partner. For research organisations: grants.
Is the call still open and how do I apply?
The 22 September 2026 deadline has passed. The next deadline indicated is 28 September 2027 at noon Paris time; the call may close earlier if the budget runs out. Check whether funds remain available and the latest version of the specifications. Before applying, check the official page and the specifications.
Official source
No official URL is available in our data for this grant.
Other grants of type “grant”
Other grants from Bpifrance
Related needs and funding
Competitive calls for projects
Ecological transition and CSR
Capital and investment funds
Support and acceleration
Diagnostics and audits
Takeover and transfer
Discover the funding that fits your company
Check your eligibility for public grants
This scheme is only one of the grants your company may be able to access. Run a personalised scan to identify the funding opportunities that match your activity, location and project.
See the opportunities identified by the scan, then access your personalised report.